InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,897.60
(
0.53%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.34
(
-0.31%
)
Bitcoin
62,370.83
(
2.62%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: opportunityknocking post# 26768

Thursday, 07/08/2010 11:51:46 AM

Thursday, July 08, 2010 11:51:46 AM

Post# of 30387
Opportunity, from everything written from Abbott, they did all their testing with RECAF involving prostate cancer. It is obvious they were wanting to combine RECAF and PSA and it is also obvious they felt it would not work to their satisfaction. That is why they are gone.

If it is not satisfactory with PSA, why do you think it would now be acceptable with others?

I'll give you a little hint Opportunity, RECAF has problems differentiating normals from abnormals and it's the reason for the large number of false positives. Two bad tests do not make a good test.

GoldSeeker™

I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up